Yu Yong (CIK 0001937482)

Latest company ownership

GNLX - GENELUX Corp

Role: SVP, Clinical Development

Shares held

134,520

Last filed at

Aug 29, 2025

Confidence Score

44.4

2025Q4

Confidence Score History

2023Q3 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Aug 21, 2025	Dec 11, 2025	GENELUX Corp	SVP, Clinical Development	Sell	26.3	-4,192	-2.79%	✗	$16K
May 12, 2025	May 13, 2025	GENELUX Corp	VP, Clinical Trial Operations	Sell	26.3	-5,579	-10.48%	✗	$16.3K
Feb 19, 2024	Jul 8, 2024	GENELUX Corp	VP, Clinical Trial Operations	Sell	91.3	+8,369	334.76%	✗	$14.5K
Dec 15, 2023	Dec 18, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	20.0	-32,535	-100.00%	✗	$428.2K
Dec 7, 2023	Dec 8, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	20.0	-36,800	-53.08%	✗	$436K
Nov 21, 2023	Nov 22, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	22.5	-18,665	-21.21%	✗	$191.6K
Nov 17, 2023	Nov 21, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	22.5	-18,135	-17.09%	✗	$210.4K
Oct 24, 2023	Oct 25, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	37.5	-5,200	-4.67%	✓	$99.4K
Oct 10, 2023	Oct 11, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	37.5	-5,200	-4.67%	✓	$114.5K
Sep 26, 2023	Sep 27, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	37.5	-5,200	-4.67%	✓	$122.5K
Sep 20, 2023	Sep 21, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	32.5	-6,000	-5.35%	✓	$167.8K
Sep 15, 2023	Sep 18, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	28.8	-10,400	-8.92%	✓	$227.6K
Sep 13, 2023	Sep 15, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	20.0	-29,800	-21.92%	✗	$629.9K
Aug 30, 2023	Aug 30, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	20.0	-19,800	-12.71%	✗	$489.1K
Aug 18, 2023	Aug 22, 2023	GENELUX Corp	VP, Clinical Trial Operations	Sell	22.5	-3,265	-2.05%	✗	$77.5K